Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2
SARS-CoV-2 continues to widely circulate in populations globally. Underdetection is acknowledged and is problematic when attempting to capture the true prevalence. Seroprevalence studies, where blood samples from a population sample are tested for SARS-CoV-2 antibodies that react to the SARS-CoV-2 v...
Main Authors: | David McConnell, Conor Hickey, Norma Bargary, Lea Trela-Larsen, Cathal Walsh, Michael Barry, Roisin Adams |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/18/9/4640 |
Similar Items
-
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
by: Maryam Shakiba, et al.
Published: (2021-02-01) -
Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA
by: Mythili Dileepan, et al.
Published: (2021-01-01) -
Pediatric SARS-CoV-2 seroprevalence during mitigation procedures in Southwestern Pennsylvania
by: Glenn J. Rapsinski, MD, PhD, et al.
Published: (2021-09-01) -
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
by: Naif Khalaf Alharbi, et al.
Published: (2021-07-01) -
Seroprevalence of anti SARS-CoV2 antibodies in Umbrian persons living with HIV
by: chiara papalini, et al.
Published: (2020-10-01)